222 related articles for article (PubMed ID: 28339386)
1. The "Lists": What Do They Mean?
Voliva J
Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
[No Abstract] [Full Text] [Related]
2. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
[No Abstract] [Full Text] [Related]
3. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
4. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
5. Introduction to Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
[TBL] [Abstract][Full Text] [Related]
6. FDA, states discuss pharmacy compounding regulatory framework.
Traynor K
Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
[No Abstract] [Full Text] [Related]
7. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
8. Improving and enforcing compounding pharmacy practices to protect patients.
Pegues DA
Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
[No Abstract] [Full Text] [Related]
9. IACP's 2016 Compounders on Capitol Hill Asks.
Int J Pharm Compd; 2016; 20(4):294-296. PubMed ID: 28333674
[No Abstract] [Full Text] [Related]
10. FDA inspections find unsafe practices in compounding pharmacies.
McCarthy M
BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
[No Abstract] [Full Text] [Related]
11. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
[TBL] [Abstract][Full Text] [Related]
12. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
Blankenship C
Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
[No Abstract] [Full Text] [Related]
13. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
14. Traditional vs. nontraditional pharmacy.
Allen LV
Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152
[No Abstract] [Full Text] [Related]
15. Drugs: just a click away. Online pharmacies can make dangerous drugs easy to get, but also can promote better health care. Should we regulate them?
Brand R
State Legis; 2007 Jun; 33(6):45, 47, 49. PubMed ID: 17546803
[No Abstract] [Full Text] [Related]
16. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
17. Meningitis outbreak shines light on compounding pharmacies.
Shaughnessy AF
BMJ; 2012 Nov; 345():e7432. PubMed ID: 23129491
[No Abstract] [Full Text] [Related]
18. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
19. Federal court strikes down compounding regulations.
Harteker LR
Am J Health Syst Pharm; 2001 Apr; 58(8):638, 640, 643. PubMed ID: 11329752
[No Abstract] [Full Text] [Related]
20. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
